Very cool preclinical plenary @MaxKonigMD Instead of CAR-T to just CD19, created CATCRs that selectively kill specific B cells (beta2 glycoprotein expressing cells) Early days but super interesting possibilities - APS, SLE, AAV, & more? #ACR22 @rheumnow #ACRBest Abstr#1677 https://t.co/nS3YtR6wN9